Asian Journal of Research in Chemistry

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Selenium as an Antioxidant: A Review


Affiliations
1 Sinhgad College of Pharmacy, Vadgaon (Bk), Pune - 411 041
2 RMP’s Bhalchandra College of Pharmacy, Gorhe (Kd), Pune - 411 042
     

   Subscribe/Renew Journal


Selenium (Se) is derived from the Greek word 'selene' meaning moon goddess. It was discovered by Jacob Berzelius of Sweden in 1817. Se (The Greek goddess of moon) is a metalloid element with atomic number 34 and an average relative atomic mass of 78.96, melting-point at about 220.5 °C, boiling-point at about 684.9 °C. It belongs to the sulphur family of elements (which also includes oxygen, tellurium and polonium), and has some common properties with sulphur, including valency and the ability to form covalent bonds with carbon. Se is specifically incorporated into proteins in the form of selenocysteine and non-specifically incorporated as selenomethionine in place of methionine. The effects of Se compounds on cells are strictly compositional and concentration-dependent. Selenium is a trace mineral found in soil, water, and some foods. It is an essential element in several metabolic pathways.

Keywords

Selenium, Antioxidants, Selenoprotein, Cancer, Heterocycles
Subscription Login to verify subscription
User
Notifications
Font Size


  • National Research Council. Food and nutrition board recommended dietary allowances, National Academy Press, Washington, DC, 1989, 10th ed.

  • Combs Jr. GF, Gray WP. Chemopreventive agents: selenium. Pharmacol Ther. 79; 1988: 179–92.

  • Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 3; 1996: 42–7.

  • Heliovaara M, Knekt P, Aho K, Aaran RK, Alfthan G, Aromaa A. Serum antioxidants and risk of rheumatoid arthritis. Ann Rheum Dis. 53; 1994: 51–3.

  • Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodefeciency virus-1 infection. Biol Trace Elem Res. 56 (1); 1997: 31–41.

  • Combs Jr. GF, Clark LC, Turnbull BW. Reduction of cancer risk with an oral supplement of selenium. Biomed Environ Sci. 10; 1997: 227–34.

  • Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother. 57; 2003: 134–44.

  • Moser PB, Reynolds RD, Acharya S, Howard MP, Andon MB, Lewis SA. Copper, iron, zinc and selenium dietary intake and status of Nepalese lactating women and their breast-fed infants. Am J Clin Nutr. 47; 1988: 729–34.

  • Brown Jr., Robert D. "Mineral Commodity Survey 1997: Selenium". United States Geological Survey. 2009. http://minerals.usgs.gov/minerals/pubs/commodity/selenium/830 398.pdf

  • Pennington JA and Young BE. Total diet study nutritional elements. J Am Diet Assoc. 91; 1991: 179-83.

  • http://www.nal.usda.gov/fnic/foodcomp

  • T. Zane Davis. "Selenium in Plants". 2008: 8. http://www.ars.usda.gov/SP2UserFiles/Place/54282000/PPClassP PSlides.

  • Burk RF. Molecular biology of selenium with implications for its metabolism. FASEB J. 9; 1991: 2274–9.

  • Bock A, Forchhammer K, Heider J, Leinfelder W, Sawers G, Veprek B, et al. Selenocysteine: the 21st amino acid. Mol Microbiol. 3; 1991: 515–20.

  • Tapiero H, Townsend DM, Tew KD. The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother. 57; 2003: 134–44.

  • Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science. 179; 1973: 588–90.

  • Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo´ R, et al. Characterization of mammalian selenopreteomes. Science. 300 (5624); 2003: 1439–43.

  • Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid hydroperoxide peroxidase. Biochim Biophys Acta. 839; 1985: 62–70.

  • Ghyselinck NB, Dufaure I, Lareyre JJ, Rigaudiere N, Mattei MG, Dufaure JP. Structural organization and regulation of the gene for the androgen-dependent.

  • Burk RF, Hill KE, Motley AK. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr. 133(5); 2003: 1517–20.

  • Kryukov GV, Kryukov VM, Gladyshev VN. New mammalian selenocysteine-containing proteins identied with an algorithm that searches for selenocysteine insertion sequence elements. J Biol Chem. 274; 1999: 33888–97.

  • Groff JL, Gropper SS, and Hunt SM. Microminerals. In: Advanced Nutrition and Human Metabolism. Minneapolis: West Publishing Company, Minneapolis. 1995: 381-384.

  • Ip C, Ganther HE. Relationship between the chemical form of selenium and anticarcinogenic activity. In: Wattenberg L, Lipkin M, Boone CW, Kelloff GJ, editors.

  • Sunde RA, Gutzke GE and Hoekstra WG. Effect of dietary methionine on the biopotency of selenite and selenomethionine in the rat. J. Nutr. Ill. 1981: 76-86.

  • Ashrafi MR, Shabanian R, Abbaskhanian A et al. Selenium and intractable epilepsy: Is there any correlation? Pediatr Neurol. 36 (1); 2007: 25-49.

  • Foster SJ, Kraus RJ et al., The metabolism of selenomethionine, Se-methylselenocysteine, their selenonium derivatives, and trimethylselenonium in the rat. Arch. Biochem. Biophys. 251; 1986: 77–86.

  • Ganther HE, Lawrence JR. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron. 53; 1997: 12229–310.

  • Hsieh HS, Ganther HE. Acid-volatile selenium formation catalyzed by glutathione reductase. Biochemistry. 14; 1975: 1632–1636.

  • Dekkers JC, Van Doornen LJP and Kemper CG. The Role of Antioxidant Vitamins and Enzymes in the Prevention of Exercise-Induced Muscle Damage. Sports Med. 21; 1996: 213- 238.

  • Spallholz JE. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed. Environ. Sci. 10; 1997: 260– 270.

  • Sigler K, Chaloupka, J, Brozmanov´a J, Stadle, N, Hofer,M. Oxidative stress in microorganisms. I. Microbial vs. higher cells damage and defenses in relation to cell aging and death. Folia Microbiol. 44; 1999: 587–624.

  • Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 266; 2004: 37–56.

  • Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic. Biol. Med. 17; 1994: 45–64.

  • Spallholz JE, Palace VP, Reid TW. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochem. Pharmacol. 67; 2004: 547–554.

  • Burk RF and Levander OA. Selenium In: Modern Nutrition in Health and Disease Ninth Edition, edited by M. Shils, J. Olson, M. Shike, and A. C. Ross. Baltimore: Williams & Wilkins, 1999, 265-276.

  • Burk RF. The significance of selenium levels in blood. In: Proceedings of the Symposium on Selenium-Tellurium in the Environment. 1976: 194-203.

  • Bardia A, Tleyjeh IM, Cerhan JR, et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc. 83(1); 2003: 23-34.

  • Duffield-Lillico AJ, Slate EH, Reid ME, et al. Selenium supplementation and secondary prevention of nonmelanoma skin cancer in a randomized trial. J Natl Cancer Inst. 95(19); 2003: 1477-1481.

  • Etminan M, FitzGerald JM, Gleave M, et al. Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control. 16(9); 2005: 1125-31.

  • Hoque A, Albanes D, Lippman SM, et al. Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial. Cancer Causes Control. 12(7); 2001: 627-33.

  • Hurwitz BE, Klaus JR, Llabre MM, et al. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial. Arch Intern Med. 167(2); 2007: 148-54.

  • Rayman M, Thompson A, Warren-Perry M, et al. Impact of selenium on mood and quality of life: a randomized, controlled trial. Biol Psychiatry. 59(2); 2006: 147-54.

  • Reid ME, Duffield-Lillico AJ, Sunga A, et al. Selenium supplementation and colorectal adenomas: an analysis of the nutritional prevention of cancer trial. Int J Cancer. 118(7); 2006: 1777-81.

  • Shaheen SO, Newson RB, Rayman MP, et al. Randomised, double blind, placebo-controlled trial of selenium supplementation in adult asthma. Thorax. 62(6); 2007: 483-90.

  • Stawicki SP, Lyons M, Aloupis M, et al. Current evidence from phase III clinical trials of selenium supplementation in critically Ill patients: why should we bother? Mini Rev Med Chem. 7(7); 2007: 693-9.

  • Stranges S, Marshall JR, Natarajan R, et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 147(4); 2007: 217-23.

  • Stranges S, Marshall JR, Trevisan M, et al. Effects of selenium supplementation on cardiovascular disease incidence and mortality: secondary analyses in a randomized clinical trial. Am J Epidemiol. 163(8); 2006: 694-9.

  • Turker O, Kumanlioglu K, Karapolat I, et al. Selenium treatment in autoimmune thyroiditis: 9-month follow-up with variable doses. J Endocrinol. 190(1); 2006: 151-6.

  • You WC, Brown LM, Zhang L, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 98(14); 2006: 974-83.

  • Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. The effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial. JAMA. 301; 2009: 39-51.

  • Ozer NK, Boscoboinik D, Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int. 35; 1995: 117-24.

  • Lapenna D, de Gioia S, Ciofani G, Mezzetti A, Ucchino S, Calafiore AM, Napolitano AM, Di Ilio C, Cuccurulo F. Glutathione-related antioxidant defenses in human atherosclerotic plaques. Circulation. 97; 1998: 1930-4.

  • Neve J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk. 3; 1996: 42-7.

  • Combs GF, Clark LC, Turnbull BW. An analysis of cancer prevention by selenium. BioFactors. 14; 2001: 153-9.

  • Look MP, Rockstroh JK, Rao GS, Kreuzer KA, Spengler U, Sauerbruch T. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection. Biol Trace Elem Res. 56(1); 1997: 31-41.

  • Singhal N and Austin J. A clinical review of micronutrients in HIV infection. J Int Assoc Physicians AIDS Care. 1; 2002: 63- 75.

  • Romero-Alvira D and Roche E. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis. Medical Hypotheses. 51(2); 1998: 169-73.

  • Patrick L. Nutrients and HIV; Part One - Beta carotene and selenium. Altern Med Rev. 4; 1999: 403-13.

  • Grimble RF. Nutritional antioxidants and the modulation of inflammation: Theory and practice. New Horizons. 2; 1994: 175- 85.

  • Aaseth J, Haugen M, Forre O. Rheumatoid arthritis and metal compounds- perspectives on the role of oxygen radical detoxification. Analyst. 123; 1998: 3-6.

  • Selenium. In: Dietary Reference Intakes for Ascorbic acid, Vitamin E, Selenium, and Carotenoids. Food and Nutrition Board, Institute of Medicine. National Academy Press, Washington DC. 7; 2000: 284-324.

  • Ravaglia et al. "Effect of micronutrient status on natural killer cell immune function in healthy free-living subjects aged >=90 y1". American Journal of Clinical Nutrition. 71 (2); 2000: 590–598.

  • MedSafe Editorial Team. "Selenium". Prescriber Update Articles. New Zealand Medicines and Medical Devices Safety Authority. http://www.medsafe.govt.nz/Profs/PUarticles/Sel.htm.

  • Essensial of Human Nutrition, Mann and Truswell, Oxford University Press, 2002. 2nd ed.

  • http://www.dheausa.com/


Abstract Views: 313

PDF Views: 2




  • Selenium as an Antioxidant: A Review

Abstract Views: 313  |  PDF Views: 2

Authors

Swati Korabu
Sinhgad College of Pharmacy, Vadgaon (Bk), Pune - 411 041
Rajani Nair
RMP’s Bhalchandra College of Pharmacy, Gorhe (Kd), Pune - 411 042
Chaitrali Pawar
RMP’s Bhalchandra College of Pharmacy, Gorhe (Kd), Pune - 411 042
Rohit Shah
Sinhgad College of Pharmacy, Vadgaon (Bk), Pune - 411 041
Priyanka Jadhav
Sinhgad College of Pharmacy, Vadgaon (Bk), Pune - 411 041
Bhakti Chorghe
Sinhgad College of Pharmacy, Vadgaon (Bk), Pune - 411 041

Abstract


Selenium (Se) is derived from the Greek word 'selene' meaning moon goddess. It was discovered by Jacob Berzelius of Sweden in 1817. Se (The Greek goddess of moon) is a metalloid element with atomic number 34 and an average relative atomic mass of 78.96, melting-point at about 220.5 °C, boiling-point at about 684.9 °C. It belongs to the sulphur family of elements (which also includes oxygen, tellurium and polonium), and has some common properties with sulphur, including valency and the ability to form covalent bonds with carbon. Se is specifically incorporated into proteins in the form of selenocysteine and non-specifically incorporated as selenomethionine in place of methionine. The effects of Se compounds on cells are strictly compositional and concentration-dependent. Selenium is a trace mineral found in soil, water, and some foods. It is an essential element in several metabolic pathways.

Keywords


Selenium, Antioxidants, Selenoprotein, Cancer, Heterocycles

References